Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis

Autor: Bakhtawar K. Mahmoodi, Niclas Eriksson, Gerrit J. A. Vos, Karina Meijer, Agneta Siegbahn, Stefan James, Lars Wallentin, Jurriën M. ten Berg

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)

Background The prothrombotic defect factor V Leiden (FVL) may confer higher risk of ST‐segment–elevation myocardial infarction (STEMI), compared with non–ST‐segment–elevation acute coronary syndrome, and may be associated with more myocardi

Externí odkaz: https://doaj.org/article/bf537e3efa32476abb9653f24fe9024a

The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model

Autor: Marianne G. Pouwer, Elsbet J. Pieterman, Lars Verschuren, Martien P. M. Caspers, Cornelis Kluft, Ricardo A. Garcia, Jurjan Aman, J. Wouter Jukema, Hans M. G. Princen

Publikováno v: Frontiers in Cardiovascular Medicine, Vol 5 (2018)

Treatment with the second and third generation BCR-ABL1 tyrosine kinase inhibitors (TKIs) increases cardiovascular risk in chronic myeloid leukemia (CML) patients. We investigated the vascular adverse effects of three generations of TKIs in a transla

Externí odkaz: https://doaj.org/article/396dba3529064ae490292c09b0bb1738

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis

Autor: Gerrit J.A. Vos, Niclas Eriksson, Karina Meijer, Lars Wallentin, Agneta Siegbahn, Bakhtawar K. Mahmoodi, Stefan James, Jurriën M. ten Berg

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Journal of the American Heart Association, 10(11):e020025. Wiley
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association, 10(11):020025. Wiley

Background The prothrombotic defect factor V Leiden (FVL) may confer higher risk of ST‐segment–elevation myocardial infarction (STEMI), compared with non–ST‐segment–elevation acute coronary syndrome, and may be associated with more myocardi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cf9d57033395c12dc1da87c959f6eb
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-447099

PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

Autor: Laura Russo, Anna Falanga, Carmen J Tartari

Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases, Vol 3, Iss 1, Pp e2011068-e2011068 (2011)

Acute promyelocytic leukemia (APL) is a distinct subtype of myeloid leukemia characterized by t(15;17) chromosomal translocation, which involves the retinoic acid receptor-alpha (RAR-alpha). APL typically presents with a life-threatening hemorrhagic

Externí odkaz: https://doaj.org/article/d89c0552a4704cb5bea280c9200c323b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.